Janssen describes adenosine A2A receptor antagonists for the treatment of Parkinson's disease June 2, 2009
EMEA accepts for review Schering-Plough's MAA for Sycrest for schizophrenia and bipolar I disorder June 2, 2009
Nanowired-based delivery of H-290/51 confers neuroprotection in rat model of heat stroke May 29, 2009
RSS